AnaptysBio's GAAP loss for 9M 2021 was $25.258 million, down 2.2 times from $53.577 million in the previous year. Revenue increased 4.1 times to $62.164 million from $15 million a year earlier.
AnaptysBio's GAAP loss for 9M 2021 was $25.258 million, down 2.2 times from $53.577 million in the previous year. Revenue increased 4.1 times to $62.164 million from $15 million a year earlier. 
ir.anaptysbio.com
English (US) 